Literature DB >> 20583208

Antipsychotics and the risk of death in the elderly: an instrumental variable analysis using two preference based instruments.

Nicole Pratt1, Elizabeth E Roughead, Philip Ryan, Amy Salter.   

Abstract

PURPOSE: Observational studies have investigated the comparative safety of antipsychotics with varying results. Instrumental variable analysis has been suggested as a possible alternative to conventional analyses when there is concern about the effect of unmeasured confounding in observational studies. Using the example of the risk of death with typical compared to atypical antipsychotics, we aimed to explore the performance of two different instruments. We used the doctor prescribing preference instrument, which has been used in previous studies, to investigate further the assumptions of this instrument in the Australian population. We also propose an alternative instrument, nursing home facility preference.
METHODS: With the Australian Department of Veterans' Affairs administrative claims database, we used an instrumental variable analysis to compare the risk of death after 12 months between the two antipsychotic classes.
RESULTS: Using the doctor prescribing preference instrument we estimated that typical antipsychotics were associated with an extra 24 (95% Confidence Interval (CI) 18-30) deaths per 100 patients per year compared to atypical antipsychotics, and an extra 10 (95% CI 7-14) deaths per 100 patients per year among nursing home residents. Facility prescribing preference was a stronger instrument (OR=19.2 95% CI 17.1-21.6) and provided a better balance of covariates than doctor prescribing preference.
CONCLUSIONS: Our study has shown that valid instruments in one population may not be directly applicable to other health care settings and testing of assumptions is crucial when performing IV analyses. Facility prescribing preference appears to be a potentially valid instrument for further work in this area. (c) 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20583208     DOI: 10.1002/pds.1942

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  13 in total

1.  Toward a clearer portrayal of confounding bias in instrumental variable applications.

Authors:  John W Jackson; Sonja A Swanson
Journal:  Epidemiology       Date:  2015-07       Impact factor: 4.822

2.  The explanatory role of stroke as a mediator of the mortality risk difference between older adults who initiate first- versus second-generation antipsychotic drugs.

Authors:  John W Jackson; Tyler J VanderWeele; Anand Viswanathan; Deborah Blacker; Sebastian Schneeweiss
Journal:  Am J Epidemiol       Date:  2014-09-18       Impact factor: 4.897

3.  Definition and evaluation of the monotonicity condition for preference-based instruments.

Authors:  Sonja A Swanson; Matthew Miller; James M Robins; Miguel A Hernán
Journal:  Epidemiology       Date:  2015-05       Impact factor: 4.822

4.  Initiation and continuation of antipsychotic medicines in older people following non-psychiatric hospital admission.

Authors:  Lisa M Kalisch Ellett; Nicole L Pratt; Jemisha Apajee; Elizabeth E Roughead
Journal:  Int J Clin Pharm       Date:  2019-06-25

5.  Evaluating possible confounding by prescriber in comparative effectiveness research.

Authors:  Jessica M Franklin; Sebastian Schneeweiss; Krista F Huybrechts; Robert J Glynn
Journal:  Epidemiology       Date:  2015-03       Impact factor: 4.822

6.  Instrumental variable applications using nursing home prescribing preferences in comparative effectiveness research.

Authors:  Krista F Huybrechts; Tobias Gerhard; Jessica M Franklin; Raisa Levin; Stephen Crystal; Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-03-24       Impact factor: 2.890

Review 7.  Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review.

Authors:  Nicole Pratt; Elizabeth E Roughead; Amy Salter; Philip Ryan
Journal:  BMC Med Res Methodol       Date:  2012-06-08       Impact factor: 4.615

8.  Bridging evidence-practice gaps: improving use of medicines in elderly Australian veterans.

Authors:  Elizabeth E Roughead; Lisa M Kalisch Ellett; Emmae N Ramsay; Nicole L Pratt; John D Barratt; Vanessa T LeBlanc; Philip Ryan; Robert Peck; Graeme Killer; Andrew L Gilbert
Journal:  BMC Health Serv Res       Date:  2013-12-12       Impact factor: 2.655

Review 9.  Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis.

Authors:  John W Jackson; Sebastian Schneeweiss; Tyler J VanderWeele; Deborah Blacker
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

10.  Integrating pharmacists into aged care facilities to improve the quality use of medicine (PiRACF Study): protocol for a cluster randomised controlled trial.

Authors:  Sam Kosari; Jane Koerner; Mark Naunton; Gregory M Peterson; Ibrahim Haider; Emily Lancsar; David Wright; Theo Niyonsenga; Rachel Davey
Journal:  Trials       Date:  2021-06-11       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.